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We recently reported that intramammary infections (IMI) caused by Staphylococcus 
chromogenes, S. xylosus and S. simulans increase the quarter milk SCC to a level that is not 
different from the level due to Staphylococcus aureus. These CNS species are therefore 
considered to be more pathogenic than the other species causing mastitis. The main objective 
of this study is to identify risk factors for both existing and new IMI specifically caused by the 
three more pathogenic CNS. 
Monthly quarter milk samples were taken from 86 cows and heifers on three commercial 
dairy farms in Flanders between September 2007 and January 2009. Potential cow-, quarter- 
and observation-level risk factors were recorded. Logistic mixed regression models were fit 
with cow and quarter as random effects to identify risk factors associated with IMI due to S. 
chromogenes, S. xylosus and S. simulans. 
Distribution of the three CNS is herd-dependent. Preliminary analyses indicate that the 
occurrence of IMI with the pathogenic CNS is associated with parity, stage of lactation, 
average daily milk production, and teat skin condition. Other risk factors such as quarter 
position, breed, body condition score and teat end condition were not associated with the 
outcome variable. 
The results of our study will allow predicting whether an animal is infected with either the 
more pathogenic or non-pathogenic species when CNS were isolated from the milk. The 
identification of risk factors for new IMI (in progress) will contribute to our knowledge on 
how to reduce the risk of IMI with those more pathogenic CNS. 
 
